Tom Krohn
@takmad.bsky.social
Child of God, husband/dad, health IT pharmacist, leader of innovation with purpose. Board member. Strategic Advisor. Pharma Lead at http://Viz.ai
This is the way you honor participants in clinical trials. Well done, BridgeBio: “For those who participated in the clinical trials for acoramidis (Attruby), there is exceptional news: BridgeBio is offering free access to Attruby for life to these patients in the US.” arci.org/attruby-attr...
FDA Approves Attruby™ (acoramidis) for the Treatment of ATTR-CM: A New Option for Patients
The FDA’s approval of Attruby is significant for patients with ATTR-CM, providing them with another effective treatment option.
arci.org
November 23, 2024 at 7:30 PM
This is the way you honor participants in clinical trials. Well done, BridgeBio: “For those who participated in the clinical trials for acoramidis (Attruby), there is exceptional news: BridgeBio is offering free access to Attruby for life to these patients in the US.” arci.org/attruby-attr...
Thanks to @craiglipset.bsky.social, @gil-bashe.bsky.social and @wilbanks.bsky.social for providing a great starting point for who to follow on Bluesky.
November 23, 2024 at 5:33 PM
Thanks to @craiglipset.bsky.social, @gil-bashe.bsky.social and @wilbanks.bsky.social for providing a great starting point for who to follow on Bluesky.